 |
|
|
|
 |
|
|
 Contact |  Print version |  PDF version |  Send article |  RSS-Feed
Cytori awarded NIH Grant to develop cell-based treatments for vascular disease21 Sep 2007 -
Cytori Therapeutics was awarded a $250,000 NIH (National Institutes of Health) Grant to develop adipose-derived regenerative cells as a treatment for vascular disease.
Regenerative cells within adipose (fat) tissue include adult stem cells and other cell types that have been shown to increase blood flow in and around damaged and oxygen deprived tissues. As a result, these cells hold exciting potential for the treatment of vascular conditions such as peripheral arterial disease, atherosclerosis, and critical limb ischemia, which impact millions of patients each year worldwide.
Additional information
Cytori Therapeutics, Inc.
San Diego, CA, United States of America
Company
News
|
National Institutes of Health (NIH)
Bethesda, Maryland, United States of America
News
|
|
|
|
|
|
Top